MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ccd.26140

Медицинская библиотека · Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2015

Implantation of everolimus-eluting bioresorbable scaffolds in a diabetic all-comers population.

Wiebe Jens, Gilbert Florian, Dörr Oliver, Liebetrau Christoph, Wilkens Eva, Bauer Timm, Elsässer Albrecht, Möllmann Helge, Hamm Christian W, Nef Holger M

Оценочное исследованиеСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Diabetes is associated with aggressive atherosclerosis, leading to an increased risk of in-stent restenosis and stent thrombosis. Bioresorbable scaffolds (BRS) are a new technology for the treatment of coronary lesions that might be beneficial due to their dissolving character, especially in diabetic patients.

OBJECTIVE

This study was designed to evaluate feasibility and mid-term clinical outcome of the implantation of PLLA-based, everolimus-eluting BRS for the treatment of coronary lesions in a diabetic all-comers population.

METHODS

All patients of an all-comers registry with diabetes eligible for BRS implantation were included. Outcome parameters were target vessel failure (TVF), major adverse cardiac events (MACE) including target lesion revascularization (TLR), cardiac death, and myocardial infarction. Follow-up was conducted via telephone and/or office visit.

RESULTS

A total of 120 diabetic patients were included. Of all diabetics, 35.0% had insulin-dependent diabetes, and all other patients were treated with oral antidiabetics or dietary modification. The median age was 67 (59-72) years and 26.7% were female. Patients underwent coronary angiography due to acute coronary syndrome in 50.8%. Of 127 lesions, 60.6% were B2/C lesions according to ACC/AHA classification. The 6-month rates of TVF, TLR, and MACE were 8.9, 2.7, and 8.4%, respectively.

CONCLUSION

This evaluation confirms reasonable clinical outcome of bioresorbable vascular scaffold implantation in a high-risk diabetic population with predominately complex lesions during daily clinical practice. Nevertheless, long-term data are required for final evaluation.

Для цитирования: Wiebe Jens, Gilbert Florian, Dörr Oliver, Liebetrau Christoph, Wilkens Eva, Bauer Timm, Elsässer Albrecht, Möllmann Helge, Hamm Christian W, Nef Holger M. Implantation of everolimus-eluting bioresorbable scaffolds in a diabetic all-comers population.. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2015. DOI: 10.1002/ccd.26140.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.